The Institut für Diabetes-Technologie (IfDT) is a research institute, specialized on clinical research in the area of diabetes mellitus.

Our aim is to support and promote research and development of technologies in the area of diabetes. With our work we want to contribute to making life for people with diabetes easier. 

We are pleased that you visit our website

At the Institut für Diabetes-Technologie (IfDT), we conduct clinical trials with medical devices in a welcoming, familiar atmosphere and offer our international customers expertise in all parts of clinical studies: starting from planning and designing over conduction up to publishing the study results.

In addition, we perform research on our own behalf regarding different aspects of diabetes.

Taken all this together made us a globally recognized and acknowledged research institute in the area of diabetes technology.     

More About Us

You are interested in taking part in a study?

We are happy if you want to actively support us in our research for the benefit of people with diabetes mellitus type 1 or type 2.

Here you can inform yourself about general conditions, procedures and prerequisites for study participation.

You want to know more about us?

Over the years the institute has grown to a worldwide recognized and acknowledged study site. Here you can learn more about our work and the institute.

You are interested in working with us?

We are always looking for motivated and committed employees who want to promote technology and research together with us. Here you can read more about the benefits we offer as an employer and our current job offers.

Current Publications

August 2023 - CGM

Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting

To support the work of the IFCC working group on CGM, we have compiled an overview of the studies on CGM accuracy over the last 20 years. The focus was not on the results, but rather on the methodology, i.e. the selected study designs and evaluation. Based on this, we make recommendations for the standardized reporting of CGM accuracy studies.

April 2023 - Glucose

Differences in venous, capillary and interstitial glucose concentrations in individuals without diabetes after glucose load

In studies on the accuracy of CGM systems, the interstitial glucose concentrations of the CGM system are compared with either capillary blood or venous blood samples. In the past, differences in the glucose concentrations of the different samples have been reported. We have now systematically investigated this in a study.

February 2023 - CGM

Performance Assessment of Three Continuous Glucose Monitoring Systems in Adults with Type 1 Diabetes

We were engaged by the non-governmental, non-profit organization FIND to test 3 CGM systems in parallel. Two of them are already available on the market, one is still under development. The background to the tests was FIND's goal of making CGM systems available in low- and middle-income countries.

Latest Congress Contributions

02 - 04 November 2023

JA-PED in Ulm

This year, the JA-PED took place in our home town Ulm. Although we were not represented in the scientific program this time, we were present with our small diabetes technology museum.

02 - 04 November 2023

Virtual Diabetes-Technology Meeting

At this annual Diabetes Technology Meeting, which was still completely virtual, we were again mainly representing the topic of CGM standardization. At the pre-meeting on November 1, the IFCC working group even had its own symposium. Dr. Freckmann and Dr. Pleus presented the results of the IFCC working group's latest publications. John Pemberton and Dr. Rolf Hinzmann were also invited to contribute. In the main meeting on November 2, Dr. Eichenlaub presented our newly developed method of displaying CGM accuracy - CG-DIVA.

22 - 23 September 2023

annual meeting of the AGDT in Ulm

The annual conference of the Diabetes and Technology Working Group of the German Diabetes Society (AGDT) took place on September 22 and 23, 2023 under the motto "Technology - Together. From practice for practice". Dr. Freckmann has been a member of the AGDT board for several years and made the institute's grounds and rooms available for the conference. The conference was attended by a total of around 110 participants. Dr. Freckmann gave a lecture on "CGM in hospitals - data and legal issues" and took part in the scientific exchange with some.

Please feel free to contact us

We are happy if you want to actively support us in our research for the benefit of people with diabetes type 1 or type 2.
In this way, you are making your own personal contribution to improving medical care.
We are looking forward to meet you!

To improve the reader-friendliness of our website, we use the generic masculine. In the context of equal treatment, we would like to point out that the content of our website is aimed at all genders and does not contain any valuation.